Fimasartan Potassium Trihydrate is an oral non-peptide angiotensin II receptor antagonist used in the clinical management of hypertension and heart failure with reduced ejection fraction. By blocking the… Read more
Fimasartan Potassium Trihydrate is an oral non-peptide angiotensin II receptor antagonist used in the clinical management of hypertension and heart failure with reduced ejection fraction. By blocking the binding of angiotensin II to AT1 receptors, this therapeutic agent effectively inhibits vasoconstriction and sodium retention. This category provides a comprehensive selection of reference standards for the active pharmaceutical ingredient, alongside its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical tasks such as impurity profiling, the validation of analytical methods, and routine quality control procedures. These standards ensure the accuracy and reliability of quantitative measurements required to maintain strict regulatory compliance throughout the drug development and manufacturing lifecycle.